To check the differentiation status of Tregs and also as inhibiting marker, we have analyzed the expression of PD1 in CD4+CD25+hi Tregs, PD1 showed lower expression in Tregs of HBV-HCC than non-HBV-HCC compared to HBV-HCC patients (Figure 6). Here, CD4 is linked to hepatocellular carcinoma.